Back to calendar
Immuneering Corporation (IMRX) Earnings
IMRX reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.31
Actual EPS: $-0.27
EPS surprise: -2.16%
Company overview
Market Cap$322.8M
PriceUSD 4.99
EPS (TTM)-1.03
52-week high10.08
52-week low3.86
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees37